Skip to main content
Biophysical Sciences Institute
Leaf for biology experiment

Our Industrial Engagement

We have a strong history of collaborating with industrial partners and applying our interdisciplinary approach to commercial biological problems. We are keen to engage through a range of activities that foster links with industrial partners from one-to-one meetings to challenge-based workshops.

Contact us for more information
Visual PDE Image - 2D Navier-Stokes

Our Innovative Community

Our members work collaboratively, breaking disciplinary boundaries to find new approaches and smart solutions to biosciences challenges.

Advancing the biophysical and biochemical sciences through interdisciplinary collaboration, pioneering discoveries, and the development of technologies that deliver meaningful impact for society, health, and industry.

Spin-out Success

By fostering a collegiate, boundary breaking culture we stimulate new innovative research directions.  For many of our members these new directions find applications as intellectual property which have formed the starting point for spin out companies. 

  • Nevrargenics Ltd wins Bionow Project of the Year Award 2025

    Nevrargenics Ltd have won the 2025 Bionow Project of the Year Award in the annual Bionow awards at the Concorde Conference Centre in Manchester. The award recognised their lead programme Ellorarxine™ as one of the most innovative and impactful life sciences projects in the UK.
    Bionow Award

  • Durham spinout secures £1.3m investment to accelerate drug discovery

    Magnitude Biosciences, a Durham University spinout founded by BSI member Professor David Weinkove and Dr Chris Saunter (previously BSI and Durham Physics), secured £1.3 million in investment to grow its drug discovery platform and expand work with pharmaceutical and biotechnology companies.
    Magnitude Biosciences

Nevrargenics Ltd wins Bionow Project of the Year Award 2025

Nevrargenics Ltd have won the 2025 Bionow Project of the Year Award in the annual Bionow awards at the Concorde Conference Centre in Manchester. The award recognised their lead programme Ellorarxine™ as one of the most innovative and impactful life sciences projects in the UK.
Bionow Award

Durham spinout secures £1.3m investment to accelerate drug discovery

Magnitude Biosciences, a Durham University spinout founded by BSI member Professor David Weinkove and Dr Chris Saunter (previously BSI and Durham Physics), secured £1.3 million in investment to grow its drug discovery platform and expand work with pharmaceutical and biotechnology companies.
Magnitude Biosciences
BSI News

Working with Partners

We work with partners on research projects, through consultancy and as partners in the delivery of advanced postgraduate training on the SOFI and MoSMed CDTs and our members are also responsible for launching spin-out companies to commercialise intellectual property developed through fundamental research. 

Our community has a strong history of collaborating with industrial partners and applying innovative approaches to real-world biological problems. In 2012 the P&G Global Business Development Vice President praised the BSI model in a talk in the US Senate to the National Governors Association “Creating an Entrepreneurial Culture”: https://www.cspan.org/video/?304528-3/creating-entrepreneurial-culturE (at 41 minutes). 

We host a range of activities to build links with industrial partners, under Non-Disclosure Agreements and Memorandum of Understandings. In the past these have included Research Discussion meetings, participation in conferences and symposium and Problem-based workshops - challenge-led closed room, NDA protected meetings.   

Please get in touch if you would like to explore working with us.